Molindone: Difference between revisions
Appearance
| [unchecked revision] | [pending revision] |
MDElliottMD (talk | contribs) Expand stub to full MedTemplate parameter set |
MDElliottMD (talk | contribs) Category taxonomy (#23): retag to house-compliant neuroleptic categories |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 8: | Line 8: | ||
| starting_dose = | | starting_dose = | ||
| preparations = | | preparations = | ||
| fda_max = | |||
| routes = | | routes = | ||
| onset = | | onset = | ||
| Line 21: | Line 22: | ||
| dosing = | | dosing = | ||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | |||
| interactions = | |||
| pregnancy_details = | | pregnancy_details = | ||
| monitoring = | | monitoring = | ||
| Line 31: | Line 31: | ||
}} | }} | ||
[[Category:First-generation neuroleptics]] | |||
[[Category:Neuroleptics]] | [[Category:Neuroleptics]] | ||
[[Category:Dihydroindolones]] | |||
Latest revision as of 14:41, 22 May 2026
Antipsychotic, Neuroleptic
Molindone
Moban
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Antipsychotic, Neuroleptic
Common uses
Pharmacy
Pharmacology
Purported mechanism
Dihydroindolone D2 antagonist